DOCSLIB.ORG

M Funds Annual Report 12.31.2020*

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Toppan Merrill - SSB_T M Fund_ Inc. Annual Report [Funds] 12-31-2020 ED [AUX] | ltolend | 25-Feb-21 14:27 | 20-39557-2.aa | Sequence: 1 CHKSUM Content: 9591 Layout: 58139 Graphics: 50912 CLEAN M FUND, INC. M International Equity Fund M Large Cap Growth Fund M Capital Appreciation Fund M Large Cap Value Fund Annual Report December 31, 2020 Beginning in February 2021, as permitted by regulations adopted by the Securities and Exchange Commission, paper copies of the Funds’ shareholder reports like this one will no longer be sent by mail, unless you specifically request paper copies of the reports from the Funds or from your financial intermediary, such as a broker-dealer or bank. Instead, the reports will be made available on a website, and you will be notified by mail each time a report is posted and provided with a website link to access the report. If you already elected to receive shareholder reports electronically, you will not be affected by this change and you need not take any action. You may elect to receive shareholder reports and other communications from the Funds electronically by calling your insurance company. If you own these shares through a financial intermediary, you may contact your financial intermediary. You may elect to receive all future reports in paper free of charge. You can inform the Funds that you wish to continue receiving paper copies of your shareholder reports by sending a request in writing to your insurance company or to your financial intermediary. Your election to receive reports in paper will apply to all funds held with the fund complex. JOB: 20-39557-2 CYCLE#;BL#: 4; 0 TRIM: 7.50" x 9.00" AS: Woburn: 781-939-0500 COLORS: Black, ~note-color 2 GRAPHICS: mfunds_inc_new_k_logo.eps V1.5 Toppan Merrill - Toppan Merrill True Blanks 7.25x9 Prospectus [Funds] ED Style Only | bvanga | 12-Aug-19 21:35 | 19-7071-4.tb | Sequence: 1 CHKSUM Content: 0 Layout: 0 Graphics: 0 CLEAN JOB: 19-7071-4 CYCLE#;BL#: 3; 0 TRIM: 7.250 x 9.000 AS: New York: 212-620-5600 COLORS: GRAPHICS: none V1.5 Toppan Merrill - SSB_T M Fund_ Inc. Annual Report [Funds] 12-31-2020 ED [AUX] | ltolend | 25-Feb-21 14:27 | 20-39557-2.ba | Sequence: 1 CHKSUM Content: 40469 Layout: 49775 Graphics: 19650 CLEAN M Fund, Inc. PRESIDENT’S LETTER Dear Contract Owners: We are pleased to share the financial condition of M Fund, Inc. (the “Corporation”) as presented in the following Annual Report dated December 31, 2020. Total assets under management at year end 2020 were $758.1 million. Sub-Advisers to the portfolios, under the direction of M Financial Investment Advisers, Inc., the investment adviser to the Corporation, have prepared the attached discussion of results for each portfolio of the Corporation for the year ended December 31, 2020. Sub-Advisers to the portfolios of the Corporation are: Dimensional Fund Advisors (“DFA”) LP for the M International Equity Fund, DSM Capital Partners LLC for the M Large Cap Growth Fund, Frontier Capital Management Company, LLC for the M Capital Appreciation Fund and Brandywine Global Investment Management, LLC for the M Large Cap Value Fund. On behalf of the Corporation’s Board of Directors, M Financial Investment Advisers, Inc. and the Corporation’s participating insurance carriers, we thank you for your business and remain committed to providing opportunities that add value to our investors in the upcoming year. Sincerely, BRIDGET MCNAMARA-FENESY President M Fund, Inc. JOB: 20-39557-2 CYCLE#;BL#: 4; 0 TRIM: 7.50" x 9.00" AS: Woburn: 781-939-0500 COLORS: Black, ~note-color 2 GRAPHICS: Bridget_McNamara-Fenesy_Sig.eps V1.5 Toppan Merrill - SSB_T M Fund_ Inc. Annual Report [Funds] 12-31-2020 ED [AUX] | ltolend | 25-Feb-21 14:27 | 20-39557-2.ba | Sequence: 2 CHKSUM Content: 15052 Layout: 46584 Graphics: 0 CLEAN M INTERNATIONAL EQUITY FUND Performance For the twelve months ended December 31, 2020, the M International Equity Fund had a return of 8.9% (net of management fees) versus a total return (including reinvestment of dividends) of 10.6% for its benchmark, the MSCI ACWI (All Country World Index) ex USA Index1. Market Environment/Conditions In US dollar terms, global ex US equity markets returned 11.12%, as reflected by the MSCI All Country World ex USA IMI (net dividends), for the year. Developed ex US markets returned 8.32% as measured by the MSCI World ex USA IMI (net dividends) and emerging markets returned 18.39% as measured by the MSCI Emerging Markets IMI (net dividends). In developed markets, all currencies appreciated versus the US dollar. In emerging markets, currency performance versus the US dollar was mixed. Most currencies generally depreciated versus the US dollar, but some, notably the Taiwan dollar and Chinese renminbi, appreciated. Theoretical and empirical research suggests that investors can systematically pursue higher expected returns by targeting the size, relative price, and profitability dimensions in equity markets. Dimensional Fund Advisors integrates these dimensions to emphasize stocks with smaller market capitalizations, lower relative prices, and higher profitability. Along the market capitalization dimension, small caps (MSCI All Country World ex USA Small Cap Index, net dividends) outperformed large caps (MSCI All Country World ex USA Index, net dividends) by 3.6% for the year. Mid caps (MSCI All Country World ex USA Mid Cap Index, net dividends), a subset of the MSCI All Country World ex USA Index universe, underperformed small caps (MSCI All Country World ex USA Small Cap Index, net dividends) by 3.9% and underperformed large caps (MSCI All Country World ex USA Index, net dividends) by 0.4%. Along the relative price dimension, large cap value stocks (MSCI All Country World ex USA Value Index, net dividends) underperformed large cap growth stocks (MSCI All Country World ex USA Growth Index, net dividends) by 23.0%, and small cap value stocks (MSCI All Country World ex USA Small Cap Value Index, net dividends) underperformed small cap growth stocks (MSCI All Country World ex USA Small Cap Growth Index, net dividends) by 19.0%. High profitability stocks outperformed low profitability stocks within large caps and underperformed within small caps.2 Performance of the premiums may vary depending on the particular segment of the market under analysis. Fund Review/Current Positioning The M International Equity Fund underperformed the MSCI All Country World ex USA Index (net dividends) by 1.7% for the period. With low relative price (value) stocks underperforming high relative price (growth) stocks, the Fund’s greater emphasis on value stocks detracted from performance relative to the benchmark. Conversely, the Fund’s inclusion of and emphasis on small cap stocks had a positive impact on performance relative to the benchmark (which is composed primarily of large and mid cap stocks), as small caps outperformed large caps. 2 JOB: 20-39557-2 CYCLE#;BL#: 4; 0 TRIM: 7.50" x 9.00" AS: Woburn: 781-939-0500 COLORS: Black, ~note-color 2 GRAPHICS: none V1.5 Toppan Merrill - SSB_T M Fund_ Inc. Annual Report [Funds] 12-31-2020 ED [AUX] | ltolend | 25-Feb-21 14:27 | 20-39557-2.ba | Sequence: 3 CHKSUM Content: 2555 Layout: 24771 Graphics: 0 CLEAN Dimensional Fund Advisors LP Investment Sub-Adviser to the M International Equity Fund Performance represented is net of fees. The foregoing reflects the thoughts and opinions of Dimensional Fund Advisors LP exclusively and is subject to change without notice. The information provided in this material should not be considered a recommendation to purchase or sell any particular security. It should not be assumed that any security transactions, holdings, or sectors discussed were or will be profitable, or that the investment recommendations or decisions we make in the future will be profitable or will equal the investment performance discussed herein. Strategies discussed are subject to change at any time by the investment manager in its discretion due to market conditions or opportunities. Market conditions may impact performance. The performance results presented were achieved in particular market conditions which may not be repeated. Moreover, the current market volatility and uncertain regulatory environment may have a negative impact on future performance. Portfolio characteristics are as of December 31, 2020. Please note that all indices are unmanaged and are not available for direct investment. The views expressed above are not guarantees of future performance or economic results and involve certain risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially from the views expressed herein. The views expressed above are subject to change at any time based upon economic, market, or other conditions and the subadvisory firm undertakes no obligation to update the views expressed herein. Any discussions of specific securities should not be considered a recommendation to buy or sell those securities. The views expressed above (including any forward-looking statement) may not be relied upon as investment advice or as an indication of the Fund’s trading intent. Information about the Fund’s holdings, asset allocation or country diversification is historical and is not an indication of future Fund composition, which may vary. Direct investment in any index is not possible. The performance of any index mentioned in this commentary has not been adjusted for ongoing management, distribution and operating expenses, and sales charges applicable to mutual fund investments. In addition, the returns do not reflect additional fees charged by separate accounts or variable insurance contracts that an investor in the Fund may pay. If these additional fees were reflected, performance would have been lower. 3 JOB: 20-39557-2 CYCLE#;BL#: 4; 0 TRIM: 7.50" x 9.00" AS: Woburn: 781-939-0500 COLORS: Black, ~note-color 2 GRAPHICS: none V1.5 Toppan Merrill - SSB_T M Fund_ Inc.
Recommended publications
  • SEI Global Investments Fund Plc Unaudited Condensed Financial Statements for the Half Year Ended 31 December 2020

    SEI Global Investments Fund Plc Unaudited Condensed Financial Statements for the Half Year Ended 31 December 2020

    SEI GLOBAL INVESTMENTS FUND PLC Unaudited Condensed Financial Statements for the half year ended 31 December 2020 SEI Global Investments Fund plc Unaudited Condensed Financial Statements for the half year ended 31 December 2020 CONTENTS PAGE Directory 3 General Information 4 Investment Adviser’s Report The SEI Global Select Equity Fund 6 Portfolio of Investments The SEI Global Select Equity Fund 9 Condensed Income Statement 26 Condensed Statement of Financial Position 27 Condensed Statement of Changes in Net Assets Attributable to Redeemable Participating Shareholders 29 Notes to the Condensed Financial Statements 31 Appendix I – Remuneration Disclosures 40 Appendix II – Statement of Changes in Composition of Portfolio 41 Appendix III – Securities Financing Transactions Regulation 42 2 SEI Global Investments Fund plc Unaudited Condensed Financial Statements for the half year ended 31 December 2020 DIRECTORY Board of Directors at 31 December 2020 Michael Jackson (Chairman) (Irish) Kevin Barr (American) Robert A. Nesher (American) Desmond Murray* (Irish) Jeffrey Klauder (American) *Director, independent of the Investment Adviser Manager SEI Investments Global, Limited 2nd Floor Styne House Upper Hatch Street Dublin 2 Ireland Investment Adviser SEI Investments Management Corporation 1 Freedom Valley Drive Oaks, Pennsylvania 19456 U.S.A. Depositary Brown Brothers Harriman Trustee Services (Ireland) Limited 30 Herbert Street Dublin 2 Ireland Administrator SEI Investments – Global Fund Services Limited 2nd Floor Styne House Upper Hatch Street
  • Morning Wrap

    Morning Wrap

    Morning Wrap Today ’s Newsflow Equity Research 19 Jul 2019 08:16 BST Upcoming Events Select headline to navigate to article Paper and Packaging Stora Enso reports weak Q2, Company Events flagging lower box prices 19-Jul Close Brothers Group; Q419 Trading Update Stora Enso ; Q219 Results Building Materials US non-residential forecasts are 23-Jul Paragon Banking; Q319 Trading Update revised down 24-Jul Britvic; Q319 Trading Update Kindred Group; Q219 Results UK Banks CBG issues a disappointing pre-close trading Marston's; Q319 Trading Update Metro Bank; Q219 Results update – NIM in focus 25-Jul AIB Group; Q219 Results Bankinter; Q219 Results Breedon Group; Interim results Howden Joinery; H1 results International Paper; Q219 Results Permanent TSB; Q219 Results Tyman; H1 results Unilever PLC; Q219 Results Wizz Air; Q120 Results Economic Events Ireland 22-Jul PPI June19 Wholesale Price Index June19 26-Jul Retail Sales June19 United Kingdom 23-Jul CBI Industrial Trends July19 25-Jul CBI Distributive Trades July19 United States Europe This document is intended for the sole use of Goodbody Stockbrokers and its affiliates Goodbody Capital Markets Equity Research +353 1 6419221 Equity Sales +353 1 6670222 Bloomberg GDSE<GO> Goodbody Stockbrokers UC, trading as “Goodbody”, is regulated by the Central Bank of Ireland. In the UK, Goodbody is authorised and subject to limited regulation by the Financial Conduct Authority. Goodbody is a member of the Irish Stock Exchange and the London Stock Exchange. Goodbody is a member of the FEXCO group of companies. For the attention of US clients of Goodbody Securities Inc, this third-party research report has been produced by our affiliate, Goodbody Stockbrokers Goodbody Morning Wrap Paper and Packaging Stora Enso reports weak Q2, flagging lower box prices Stora Enso has reported Q2 results to the end of June.
  • Annual Report and Accounts for the Year Ended 31 December 2020

    Annual Report and Accounts for the Year Ended 31 December 2020

    Tyman plc Annual report and accounts TYMAN PLC for the year ended 31 December 2020 Annual report and accounts for the year ended 31 December 2020 Annual report and accounts for the year The expert touch that transforms Tyman is a leading international supplier of engineered fenestration components and access solutions to the construction industry. Highlights • Strong recovery from COVID-19 in H2 saw growth of 5% against £572.8m 1.1× 4.0p £100.6m H2 2019; full year LFL revenue down 6% Revenue Leverage* Dividend per share Adjusted net debt* • Cost reductions and benefits of self-help initiatives mitigated the full (2019: £613.7m) (2019: 1.7×) (2019: 3.9p) (2019: £164.5m) year revenue shortfall, resulting in adjusted operating margin slightly ahead of 2019 and LFL adjusted operating profit down only 6% • Good progress on self-help measures: £80.3m 27.2p £47.6m 19.1p − Encouraging level of North American customer wins Adjusted operating profit* Adjusted earnings per share* Profit before taxation Basic earnings per share − Successful execution of planned footprint realignments (2019: £85.4m) (2019: 27.5p) (2019: £24.8m) (2019: 9.1p) − Momentum gained with continuous improvement activities • Strategic initiatives continued to bear fruit, driving market share gains across the Group • Reduction in safety incidents of 22% indicative of operational excellence progress • Strong cash generation with cash conversion of 131% and reduction in leverage to 1.1x, achieving low-end of new target range • Repayment in December 2020 of £2.3m received under
  • ES River and Mercantile UK Recovery Fund

    ES River and Mercantile UK Recovery Fund

    ES River and Mercantile UK Recovery Fund Quarterly Report to 30 September 2020 UK Equity Unconstrained Fund I Monthly Report Month 2008 UK Recovery For unitholders only0 ES R&M UK Recovery Fund Quarter 3, 2020 Fund Objective The investment objective of the Fund is to grow the value of your investment (known as “capital growth”) in excess of the MSCI United Kingdom Investable Market Index (IMI) Net Total Return (the “Benchmark”) over a rolling 5 year period, after the deduction of fees. Performance (net of fees) B share class Benchmark Difference 3 Months -1.4% -3.6% 2.2% 1 Year -17.1% -18.5% 1.4% 3 Years p.a. -5.9% -4.1% -1.8% 5 Years p.a. 3.8% 3.0% 0.8% 10 Years p.a. 7.8% 4.6% 3.1% Since Inception p.a. 12.6% 7.9% 4.7% 20% 10% 0% -10% -20% -30% 3 Months 1 Year 3 Years 5 Years 10 Years Since Inception p.a. p.a. p.a. p.a. ES R&M UK Recovery Fund B Shares MSCI UK IM Index Performance (gross of fees) Z class Z share class Benchmark Difference 3 Months -1.2% -3.6% 2.4% 1 Year -16.2% -18.5% 2.3% 3 Years p.a. -5.0% -4.1% -0.9% 5 Years p.a. 4.8% 3.0% 1.9% 10 Years p.a. 8.9% 4.6% 4.2% Source: River and Mercantile Asset Management LLP. Benchmark is the MSCI UK Investable Market index, net GBP.
  • Gallery Trust Form N-PX Filed 2021-08-30

    Gallery Trust Form N-PX Filed 2021-08-30

    SECURITIES AND EXCHANGE COMMISSION FORM N-PX Annual report of proxy voting record of registered management investment companies filed on Form N-PX Filing Date: 2021-08-30 | Period of Report: 2021-06-30 SEC Accession No. 0001135428-21-000174 (HTML Version on secdatabase.com) FILER Gallery Trust Mailing Address Business Address ONE FREEDOM VALLEY ONE FREEDOM VALLEY CIK:1651872| IRS No.: 000000000 | State of Incorp.:DE | Fiscal Year End: 1031 DRIVE DRIVE Type: N-PX | Act: 40 | File No.: 811-23091 | Film No.: 211223361 OAKS PA 19456 OAKS PA 19456 (610) 676-1000 Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________ FORM N-PX ________ ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act File Number: 811-23091 Gallery Trust (Exact name of registrant as specified in charter) ________ SEI Investments One Freedom Valley Drive Oaks, PA 19456 (Address of principal executive offices) ________ Michael Beattie c/o SEI Investments One Freedom Valley Drive Oaks, PA 19456 (Name and address of agent for service) ________ Registrant’s telephone number, including area code: 1-888-832-4386 Date of Fiscal Year End: October 31 Date of Reporting Period: July 1, 2020 to June 30, 2021 Item 1. Proxy Voting Record. Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document Attached are the proxy voting records for the following funds, each of which is a series of Gallery Trust: Mondrian Emerging Markets Value Equity Fund Mondrian Global Equity Value Fund (The Mondrian Global Equity Value Fund commenced operations on June 30, 2020) Mondrian Global Listed Infrastructure Fund Mondrian International Government Fixed Income Fund Mondrian International Value Equity Fund Mondrian U.S.
  • Opioid Dependence: Buprenorphine Prolonged- Release Injection (Buvidal)

    Opioid Dependence: Buprenorphine Prolonged- Release Injection (Buvidal)

    Evidence review Opioid dependence: buprenorphine prolonged- release injection (Buvidal) Publication date: February 2019 This evidence review sets out the best available evidence on buprenorphine prolonged-release injection (Buvidal) for treating opioid dependence. It should be read in conjunction with the evidence summary, which gives the key messages. Commissioned by Public Health England. Disclaimer The content of this evidence review was up-to-date in February 2019. See summaries of product characteristics (SPCs), British national formulary (BNF) or the Medicines and Healthcare products Regulatory Agency (MHRA) or NICE websites for up-to-date information. Copyright © NICE 2019. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3246-7 Evidence review: Opioid dependence: buprenorphine prolonged-release injection (Buvidal) (February 2019) 2 of 29 Contents Contents ..................................................................................................................... 3 Background ................................................................................................................ 4 Product overview ........................................................................................................ 4 Mode of action ........................................................................................................ 4 Regulatory status .................................................................................................... 4 Dosing information .................................................................................................
  • Fund Holdings

    Fund Holdings

    Wilmington International Fund as of 7/31/2021 (Portfolio composition is subject to change) ISSUER NAME % OF ASSETS ISHARES MSCI CANADA ETF 3.48% TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 2.61% DREYFUS GOVT CASH MGMT-I 1.83% SAMSUNG ELECTRONICS CO LTD 1.79% SPDR S&P GLOBAL NATURAL RESOURCES ETF 1.67% MSCI INDIA FUTURE SEP21 1.58% TENCENT HOLDINGS LTD 1.39% ASML HOLDING NV 1.29% DSV PANALPINA A/S 0.99% HDFC BANK LTD 0.86% AIA GROUP LTD 0.86% ALIBABA GROUP HOLDING LTD 0.82% TECHTRONIC INDUSTRIES CO LTD 0.79% JAMES HARDIE INDUSTRIES PLC 0.78% DREYFUS GOVT CASH MGMT-I 0.75% INFINEON TECHNOLOGIES AG 0.74% SIKA AG 0.72% NOVO NORDISK A/S 0.71% BHP GROUP LTD 0.69% PARTNERS GROUP HOLDING AG 0.65% NAVER CORP 0.61% HUTCHMED CHINA LTD 0.59% LVMH MOET HENNESSY LOUIS VUITTON SE 0.59% TOYOTA MOTOR CORP 0.59% HEXAGON AB 0.57% SAP SE 0.57% SK MATERIALS CO LTD 0.55% MEDIATEK INC 0.55% ADIDAS AG 0.54% ZALANDO SE 0.54% RIO TINTO LTD 0.52% MERIDA INDUSTRY CO LTD 0.52% HITACHI LTD 0.51% CSL LTD 0.51% SONY GROUP CORP 0.50% ATLAS COPCO AB 0.49% DASSAULT SYSTEMES SE 0.49% OVERSEA-CHINESE BANKING CORP LTD 0.49% KINGSPAN GROUP PLC 0.48% L'OREAL SA 0.48% ASSA ABLOY AB 0.46% JD.COM INC 0.46% RESMED INC 0.44% COLOPLAST A/S 0.44% CRODA INTERNATIONAL PLC 0.41% AUSTRALIA & NEW ZEALAND BANKING GROUP LTD 0.41% STRAUMANN HOLDING AG 0.41% AMBU A/S 0.40% LG CHEM LTD 0.40% LVMH MOET HENNESSY LOUIS VUITTON SE 0.39% SOFTBANK GROUP CORP 0.39% NOVARTIS AG 0.38% HONDA MOTOR CO LTD 0.37% TOMRA SYSTEMS ASA 0.37% IMCD NV 0.37% HONG KONG EXCHANGES & CLEARING LTD 0.36% AGC INC 0.36% ADYEN
  • Summary of Investments by Type

    Summary of Investments by Type

    COMMON INVESTMENT FUNDS Schedule of Investments March 31, 2017 SUMMARY OF INVESTMENTS BY TYPE Cost Market Value Fixed Income Investments $ $ Short-term investments 42,653,484 42,653,484 Bonds 175,482,352 175,327,122 Mortgage-backed securities 22,199,796 21,785,061 Emerging markets debt 9,619,817 10,899,147 Bank loans - high income fund 20,985,176 23,595,337 Total Fixed Income Investments 270,940,624 274,260,151 Equity-Type Investments Mutual funds Domestic 9,234,353 12,420,750 International 18,849,681 18,688,379 Common stocks Domestic 152,833,551 187,487,257 International 216,167,277 227,850,648 Total Equity-Type Investments 397,084,862 446,447,034 Alternative Investments Funds of hedge funds 38,264,990 46,247,453 Real estate trust fund 6,876,041 10,104,141 Total Alternatives Investments 45,141,031 56,351,594 TOTAL INVESTMENTS 713,166,517 777,058,779 Page 1 of 32 COMMON INVESTMENT FUNDS Schedule of Investments March 31, 2017 SUMMARY OF INVESTMENTS BY FUND Cost Market Value Fixed Income Fund $ $ Short-term investments 13,092,627 13,092,627 Bonds 143,036,345 143,362,214 Mortgage-backed securities 21,372,523 20,977,317 Emerging markets debt 9,619,817 10,899,147 Bank loans - high income fund 20,985,176 23,595,337 208,106,487 211,926,642 Domestic Core Equity Fund Short-term investments 9,127,791 9,127,791 Common stocks 134,983,626 165,021,220 Futures - (5,950) Private placement 4,150 4,150 144,115,567 174,147,211 Small Cap Equity Fund Short-term investments 2,937,066 2,937,066 Mutual funds 9,234,353 12,420,750 Common stocks 17,845,775 22,467,836
  • Medications for Opioid Use Disorder for Healthcare and Addiction Professionals, Policymakers, Patients, and Families

    Medications for Opioid Use Disorder for Healthcare and Addiction Professionals, Policymakers, Patients, and Families

    Medications for Opioid Use Disorder For Healthcare and Addiction Professionals, Policymakers, Patients, and Families UPDATED 2020 TREATMENT IMPROVEMENT PROTOCOL TIP 63 Please share your thoughts about this publication by completing a brief online survey at: https://www.surveymonkey.com/r/KAPPFS The survey takes about 7 minutes to complete and is anonymous. Your feedback will help SAMHSA develop future products. TIP 63 MEDICATIONS FOR OPIOID USE DISORDER Treatment Improvement Protocol 63 For Healthcare and Addiction Professionals, Policymakers, Patients, and Families This TIP reviews three Food and Drug Administration-approved medications for opioid use disorder treatment—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support people in recovery. TIP Navigation Executive Summary For healthcare and addiction professionals, policymakers, patients, and families Part 1: Introduction to Medications for Opioid Use Disorder Treatment For healthcare and addiction professionals, policymakers, patients, and families Part 2: Addressing Opioid Use Disorder in General Medical Settings For healthcare professionals Part 3: Pharmacotherapy for Opioid Use Disorder For healthcare professionals Part 4: Partnering Addiction Treatment Counselors With Clients and Healthcare Professionals For healthcare and addiction professionals Part 5: Resources Related to Medications for Opioid Use Disorder For healthcare and addiction professionals, policymakers, patients, and families MEDICATIONS FOR OPIOID USE DISORDER TIP 63 Contents
  • Electra Private Equity

    Electra Private Equity

    Electra Private Equity PLC EQUITY PLC ELECTRA PRIVATE Paternoster House 65 St Paul’s Churchyard London EC4M 8AB T: +44 (0)20 7214 4200 www.electraequity.com Electra Private Equity PLC Report and Accounts REPORT AND ACCOUNTS 2014 REPORT AND ACCOUNTS This Report and Accounts is printed on FSC® certified paper, using fully sustainable, vegetable oil-based inks. The paper supplying mill is ISO 9001, ISO 14001 and OHSAS 18001 certified and operates to EMAS standards. The mill is fully integrated, manufacturing pulp and paper on site, therefore reducing energy consumption and carbon output. Printed by Nicholas Gray Limited. www.nicgray.com 30 September 2014 Contents Overview 1 About Electra Private Equity 2 Financial Highlights 3 Long-term Performance Strategic and business review 4 Chairman’s Statement 7 Strategic Report Managers’ Review 14 The Manager 20 Investment Highlights 22 Portfolio Overview 24 Portfolio Review 31 Market Review 32 Key New Investments and Realisations 42 Key Investments 44 Large Private Equity Investments 58 Financial Review Financial Statements 61 Consolidated Income Statement 61 Consolidated Statement of Comprehensive Income 62 Consolidated Statement of Changes in Equity 63 Company Statement of Changes in Equity 64 Consolidated Balance Sheet 65 Company Balance Sheet 66 Consolidated Cash Flow Statement 67 Company Cash Flow Statement 68 Notes to the Financial Statements 98 Independent Auditors Report Governance 106 Objective and Investment Policy 107 Report of the Directors 114 Directors’ Remuneration Report 119 Corporate Governance 124 Report of the Audit Committee 126 Statement of Directors’ Responsibilities Further Information 128 Board of Directors 130 Alternative Investment Fund Managers Directive 134 Information for Shareholders 137 Ten Year Record 138 Glossary 140 Notice of Annual General Meeting 143 Contact Details References in this announcement to Electra Private Equity PLC and its subsidiaries have been abbreviated to ‘Electra’ or the ‘Company’.
  • Tyman Plc Annual Report and Accounts 2016 Accounts and Report Annual

    Tyman Plc Annual Report and Accounts 2016 Accounts and Report Annual

    Tyman plc Tyman Annual Report and Accounts 2016 A year of growth Tyman plc Annual Report and Accounts 2016 Further progress and growth through acquisitions Tyman is a leading international supplier of engineered components to the door and window industry. At 31 December 2016 the Group had 23 manufacturing sites in eight countries along with a further 18 sourcing and distribution sites across North America, Europe, South America, Asia and Australasia with its products being found in homes and buildings worldwide. Operational highlights Financial highlights • Year of profitable growth assisted by contributions from strategic acquisitions and favourable exchange rates Revenue Dividend per share • Integration of the three acquisitions completed in the year now well advanced £457.6m 10.50p 2015: £353.4m +29% 2015: 8.75p +20% • Synergy targets for both Giesse and Bilco now expected to be achieved by the end of 2017 - significantly ahead of schedule Underlying operating profit Underlying net debt • Strong cash generation and tight control over working £69.8m £176.7m capital taking Leverage back below 2.00x at the year end 2015: £51.4m +36% 2015: £83.2m (112)% • Dividend increased by 20.0 per cent to reflect improved cash generation and profitability Profit before taxation Leverage • Continued margin progression in AmesburyTruth despite limited volume growth £29.4m 1.89x 2015: £15.6m +89% 2015: 1.35x • Stronger second half for ERA with UK markets holding up better than expected post the EU Referendum Underlying earnings per share Return on capital
  • Portfolio of Investments

    Portfolio of Investments

    PORTFOLIO OF INVESTMENTS Variable Portfolio – Partners International Value Fund, September 30, 2020 (Unaudited) (Percentages represent value of investments compared to net assets) Investments in securities Common Stocks 97.9% Common Stocks (continued) Issuer Shares Value ($) Issuer Shares Value ($) Australia 4.2% UCB SA 3,232 367,070 AMP Ltd. 247,119 232,705 Total 13,350,657 Aurizon Holdings Ltd. 64,744 199,177 China 0.6% Australia & New Zealand Banking Group Ltd. 340,950 4,253,691 Baidu, Inc., ADR(a) 15,000 1,898,850 Bendigo & Adelaide Bank Ltd. 30,812 134,198 China Mobile Ltd. 658,000 4,223,890 BlueScope Steel Ltd. 132,090 1,217,053 Total 6,122,740 Boral Ltd. 177,752 587,387 Denmark 1.9% Challenger Ltd. 802,400 2,232,907 AP Moller - Maersk A/S, Class A 160 234,206 Cleanaway Waste Management Ltd. 273,032 412,273 AP Moller - Maersk A/S, Class B 3,945 6,236,577 Crown Resorts Ltd. 31,489 200,032 Carlsberg A/S, Class B 12,199 1,643,476 Fortescue Metals Group Ltd. 194,057 2,279,787 Danske Bank A/S(a) 35,892 485,479 Harvey Norman Holdings Ltd. 144,797 471,278 Demant A/S(a) 8,210 257,475 Incitec Pivot Ltd. 377,247 552,746 Drilling Co. of 1972 A/S (The)(a) 40,700 879,052 LendLease Group 485,961 3,882,083 DSV PANALPINA A/S 15,851 2,571,083 Macquarie Group Ltd. 65,800 5,703,825 Genmab A/S(a) 1,071 388,672 National Australia Bank Ltd.